ATE126792T1 - 3-aryl-oxazolidinone, verfahren zu ihrer herstellung und ihre anwendung in der therapie. - Google Patents

3-aryl-oxazolidinone, verfahren zu ihrer herstellung und ihre anwendung in der therapie.

Info

Publication number: ATE126792T1
Authority: AT; Austria
Prior art keywords: group; alkyl; chain; groups; oxazolidinone
Prior art date: 1989-10-17

Application number

AT90402891T

Other languages

English (en)

Inventor

Francois-Xavier Jarreau

Vincenzo Rovei

Jean-Jacques Koenig

Alain Schoofs

Original Assignee

Delalande Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-10-17

Filing date

1990-10-16

Publication date

1995-09-15

1990-10-16 Application filed by Delalande Sa filed Critical Delalande Sa

1995-09-15 Application granted granted Critical

1995-09-15 Publication of ATE126792T1 publication Critical patent/ATE126792T1/de

Links

238000000034 method Methods 0.000 title 1
238000002560 therapeutic procedure Methods 0.000 title 1
125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 6
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 2
125000000753 cycloalkyl group Chemical group 0.000 abstract 2
125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 2
125000004430 oxygen atom Chemical group O* 0.000 abstract 2
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
JNCMHMUGTWEVOZ-UHFFFAOYSA-N F[CH]F Chemical compound F[CH]F JNCMHMUGTWEVOZ-UHFFFAOYSA-N 0.000 abstract 1
108010081348 HRT1 protein Hairy Proteins 0.000 abstract 1
102100021881 Hairy/enhancer-of-split related with YRPW motif protein 1 Human genes 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Neurology (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Anesthesiology (AREA)
Epidemiology (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Steroid Compounds (AREA)

AT90402891T 1989-10-17 1990-10-16 3-aryl-oxazolidinone, verfahren zu ihrer herstellung und ihre anwendung in der therapie. ATE126792T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR8913555A FR2653017B1 (fr)	1989-10-17	1989-10-17	Derives d'aryl-3 oxazolidinone-2, leur procede de preparation et leur application en therapeutique.

Publications (1)

Publication Number	Publication Date
ATE126792T1 true ATE126792T1 (de)	1995-09-15

Family

ID=9386480

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT90402892T ATE126220T1 (de)	1989-10-17	1990-10-16	3-aryl-oxazolidinone-derivate, verfahren zu ihrer herstellung und ihre anwendung in der therapie.
AT90402891T ATE126792T1 (de)	1989-10-17	1990-10-16	3-aryl-oxazolidinone, verfahren zu ihrer herstellung und ihre anwendung in der therapie.

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AT90402892T ATE126220T1 (de)	1989-10-17	1990-10-16	3-aryl-oxazolidinone-derivate, verfahren zu ihrer herstellung und ihre anwendung in der therapie.

Country Status (15)

Country	Link
US (3)	US5036090A (de)
EP (3)	EP0424244B1 (de)
JP (3)	JPH04502335A (de)
KR (3)	KR920701178A (de)
AT (2)	ATE126220T1 (de)
AU (3)	AU637150B2 (de)
CA (3)	CA2027715A1 (de)
DE (2)	DE69021498T2 (de)
DK (1)	DK0424244T3 (de)
ES (1)	ES2078958T3 (de)
FR (1)	FR2653017B1 (de)
GR (1)	GR3017708T3 (de)
NZ (3)	NZ235727A (de)
WO (3)	WO1991005776A1 (de)
ZA (3)	ZA908283B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5235063A (en) *	1989-10-17	1993-08-10	Delalande S.A.	Process of preparing by condensation certain
FR2653017B1 (fr) *	1989-10-17	1995-05-05	Delalande Sa	Derives d'aryl-3 oxazolidinone-2, leur procede de preparation et leur application en therapeutique.
US5196543A (en) *	1989-10-17	1993-03-23	Delalande S.A.	3-aryloxazolidinone derivatives, process for their preparation and their use in therapy
FR2675504B1 (fr) *	1991-04-16	1995-01-27	Delalande Sa	Derives d'aryl-3 oxazolidinone, leur procede de preparation et leur application en therapeutique.
TW286317B (de) *	1993-12-13	1996-09-21	Hoffmann La Roche
FR2715155B1 (fr) *	1994-01-19	1996-07-26	Mayoly Spindler	Inhibiteurs de la monoamine oxydase B et leurs procédés de préparation.
DE4429461A1 (de) *	1994-08-19	1996-02-22	Merck Patent Gmbh	Adhäsionsrezeptor-Antagonisten
FR2732679B1 (fr) *	1995-04-07	1997-04-30	Synthelabo	Procede de preparation enzymatique d'un intermediaire de synthese de la befloxatone
FR2734821B1 (fr) *	1995-06-02	1997-07-11	Synthelabo	Derives de 5-methoxymethyl-3-(1,2-benzisoxazol-3-yl) oxazolidin-2-one, leur preparation et leur application en therapeutique
HU224879B1 (en) *	1995-06-02	2006-03-28	Sanofi Aventis	Oxazolidinone derivatives, their preparation and pharmaceutical compositions containing these compounds
FR2734820B1 (fr) *	1995-06-02	1997-07-11	Synthelabo	Derives de 3-(1,2-benzisoxazol-3-yl)oxazolidin-2-one, leur preparation et leur application en therapeutique
FR2737206B1 (fr) *	1995-07-24	1997-08-22	Synthelabo	Derives d'oxazoloquinoleinone, leur preparation et leur application en therapeutique
FR2741071B1 (fr) *	1995-11-09	1997-12-12	Synthelabo	Derives de 3-(benzofuran-5-yl)oxazolidin-2-one, leur preparation et leur application en therapeutique
FR2741072B1 (fr) *	1995-11-09	1997-12-12	Synthelabo	Derives d'oxazolidin-2-one, leur preparation et leur application en therapeutique
US6642409B2 (en)	2000-01-27	2003-11-04	Central Glass Company, Limited	Process for producing 4,4,4-trifluoro-3-hydroxybutyric acid derivatives
US6444813B2 (en) *	2000-02-02	2002-09-03	Pharmacia & Upjohn Company	Linezolid-crystal form II
WO2002018354A1 (en) *	2000-08-31	2002-03-07	Abbott Laboratories	Oxazolidinones and their use as antibacterial agents
IL163666A0 (en)	2002-02-22	2005-12-18	New River Pharmaceuticals Inc	Active agent delivery systems and methods for protecting and administering active agents
PE20211706A1 (es) *	2018-09-14	2021-09-01	Fmc Corp	Hidratos y cetonas de halometilo fungicidas

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
LU80081A1 (fr) *	1977-08-26	1979-05-15	Delalande Sa	Nouvelles hydroxymethyl-5 oxazolidinones-2,leur procede de preparation et leur application therapeutique
FR2506769A2 (fr) *	1978-06-09	1982-12-03	Delalande Sa	Para-((cyano-5 n pentyl-1) phenyl)-3 methoxymethyl-5 oxazolidinone-2, son procede de preparation et ses applications en therapeutique
FR2458547B2 (fr) *	1978-06-09	1986-05-16	Delalande Sa	Nouvelles n-aryle azolones, leur procede de preparation et leur application en therapeutique
US4348393A (en) *	1978-06-09	1982-09-07	Delalande S.A.	N-Aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones
CA1171865A (en) *	1980-06-04	1984-07-31	Alain Lacour	N-aryl azolone derivatives, the process for preparing the same and their application in therapeutics
FR2608604B1 (fr) *	1986-12-19	1989-04-28	Delalande Sa	Derives 5-hydroxyethyles de l'oxazolidinone-2, leurs procedes de preparation et leurs applications en therapeutique
FR2653017B1 (fr) *	1989-10-17	1995-05-05	Delalande Sa	Derives d'aryl-3 oxazolidinone-2, leur procede de preparation et leur application en therapeutique.

1989
- 1989-10-17 FR FR8913555A patent/FR2653017B1/fr not_active Expired - Fee Related
1990
- 1990-10-15 US US07/597,426 patent/US5036090A/en not_active Expired - Fee Related
- 1990-10-15 US US07/597,583 patent/US5036091A/en not_active Expired - Lifetime
- 1990-10-16 CA CA002027715A patent/CA2027715A1/en not_active Abandoned
- 1990-10-16 EP EP90402892A patent/EP0424244B1/de not_active Expired - Lifetime
- 1990-10-16 DK DK90402892.5T patent/DK0424244T3/da active
- 1990-10-16 EP EP90402891A patent/EP0424243B1/de not_active Expired - Lifetime
- 1990-10-16 AT AT90402892T patent/ATE126220T1/de not_active IP Right Cessation
- 1990-10-16 CA CA002027782A patent/CA2027782C/en not_active Expired - Fee Related
- 1990-10-16 DE DE69021498T patent/DE69021498T2/de not_active Expired - Lifetime
- 1990-10-16 US US07/598,254 patent/US5171747A/en not_active Expired - Fee Related
- 1990-10-16 CA CA002027783A patent/CA2027783C/en not_active Expired - Lifetime
- 1990-10-16 EP EP90402893A patent/EP0428421A1/de not_active Withdrawn
- 1990-10-16 ES ES90402892T patent/ES2078958T3/es not_active Expired - Lifetime
- 1990-10-16 AT AT90402891T patent/ATE126792T1/de active
- 1990-10-16 DE DE69021823T patent/DE69021823T2/de not_active Expired - Fee Related
- 1990-10-17 AU AU64713/90A patent/AU637150B2/en not_active Ceased
- 1990-10-17 JP JP2514789A patent/JPH04502335A/ja active Pending
- 1990-10-17 ZA ZA908283A patent/ZA908283B/xx unknown
- 1990-10-17 KR KR1019910700620A patent/KR920701178A/ko not_active Withdrawn
- 1990-10-17 ZA ZA908284A patent/ZA908284B/xx unknown
- 1990-10-17 WO PCT/FR1990/000747 patent/WO1991005776A1/fr not_active Ceased
- 1990-10-17 KR KR1019910700618A patent/KR920701176A/ko not_active Abandoned
- 1990-10-17 WO PCT/FR1990/000746 patent/WO1991005775A1/fr not_active Ceased
- 1990-10-17 JP JP2514788A patent/JPH07103114B2/ja not_active Expired - Lifetime
- 1990-10-17 NZ NZ235727A patent/NZ235727A/en unknown
- 1990-10-17 KR KR1019910700619A patent/KR0149508B1/ko not_active Expired - Lifetime
- 1990-10-17 AU AU64714/90A patent/AU637413B2/en not_active Expired
- 1990-10-17 AU AU64715/90A patent/AU635779B2/en not_active Ceased
- 1990-10-17 NZ NZ235728A patent/NZ235728A/en unknown
- 1990-10-17 JP JP2514787A patent/JPH04502333A/ja active Pending
- 1990-10-17 ZA ZA908285A patent/ZA908285B/xx unknown
- 1990-10-17 WO PCT/FR1990/000745 patent/WO1991005774A1/fr not_active Ceased
- 1990-10-17 NZ NZ235729A patent/NZ235729A/en unknown
1995
- 1995-10-11 GR GR950402817T patent/GR3017708T3/el unknown

Also Published As

Publication number	Publication date
EP0424243B1 (de)	1995-08-23
NZ235727A (en)	1992-04-28
CA2027783C (en)	1996-04-30
CA2027783A1 (en)	1991-04-18
DK0424244T3 (da)	1996-01-02
WO1991005775A1 (fr)	1991-05-02
JPH04502335A (ja)	1992-04-23
JPH04502334A (ja)	1992-04-23
ZA908284B (en)	1991-08-28
AU6471590A (en)	1991-06-20
DE69021498D1 (de)	1995-09-14
HK1005591A1 (en)	1999-01-15
CA2027782A1 (en)	1991-04-18
EP0428421A1 (de)	1991-05-22
FR2653017B1 (fr)	1995-05-05
EP0424243A1 (de)	1991-04-24
CA2027715A1 (en)	1991-04-18
EP0424244B1 (de)	1995-08-09
JPH04502333A (ja)	1992-04-23
CA2027782C (en)	1996-04-30
US5171747A (en)	1992-12-15
AU635779B2 (en)	1993-04-01
EP0424244A1 (de)	1991-04-24
FR2653017A1 (fr)	1991-04-19
GR3017708T3 (en)	1996-01-31
KR920701176A (ko)	1992-08-11
ATE126220T1 (de)	1995-08-15
KR920701177A (ko)	1992-08-11
JPH07103114B2 (ja)	1995-11-08
NZ235729A (en)	1992-05-26
KR0149508B1 (ko)	1998-10-15
ZA908283B (en)	1991-08-28
AU6471490A (en)	1991-07-18
DE69021823T2 (de)	1996-07-11
KR920701178A (ko)	1992-08-11
DE69021498T2 (de)	1996-03-28
NZ235728A (en)	1992-04-28
AU637150B2 (en)	1993-05-20
US5036090A (en)	1991-07-30
WO1991005774A1 (fr)	1991-05-02
WO1991005776A1 (fr)	1991-05-02
AU6471390A (en)	1991-06-20
AU637413B2 (en)	1993-05-27
ZA908285B (en)	1991-08-28
DE69021823D1 (de)	1995-09-28
US5036091A (en)	1991-07-30
ES2078958T3 (es)	1996-01-01

Publication	Publication Date	Title
ATE126792T1 (de)	1995-09-15	3-aryl-oxazolidinone, verfahren zu ihrer herstellung und ihre anwendung in der therapie.
DE3576690D1 (de)	1990-04-26	Pyrimidopyrimidinderivate, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische zubereitungen und ihre verwendung als anti-allergische mittel.
DE68903437D1 (de)	1992-12-17	Piperidin-derivate.
WO1995001170A3 (en)	2002-02-14	Use of phenethanolamine derivatives in the treatment of gastrointestinal disorders
ATE173252T1 (de)	1998-11-15	Arylmorpholine, herstellung und verwendung
DE3864707D1 (de)	1991-10-17	Benzoxazin-derivate und verfahren zu ihrer herstellung.
ATE161012T1 (de)	1997-12-15	6-oxo-azepinoindol-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
ATE40554T1 (de)	1989-02-15	Furo(3,2-c>pyridinderivate, ihre herstellung und ihre therapeutische verwendung.
ATE2431T1 (de)	1983-03-15	2,3-dihydroimidazo (1,2-b) pyridazin-derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
IE45200L (en)	1977-11-21	Pharmaceutical composition
ATE42291T1 (de)	1989-05-15	Spiro(indolo(1,7-ab>(1,5>benzodiazepin-2,4'piperidine> und zwischenprodukte, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel.
ATE73767T1 (de)	1992-04-15	Fluorine enthaltende vitamin-d3-derivate und verfahren zu ihrer herstellung.
DE59005819D1 (de)	1994-06-30	9-fluor-prostaglandin-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
ATE7893T1 (de)	1984-06-15	10b-carboxy-aminoborane, verfahren zur herstellung derselben sowie ihre verwendung als arzneimittel zur neutroneneinfangtherapie.